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Abstract
The human formyl-peptide receptor 2 (FPR2/ALX) senses phenol-soluble modulin (PSM) peptide toxins produced by
pathogenic staphylococcal species and plays a crucial role in directing neutrophil influx during staphylococcal infection.
However, it has remained unclear if FPR2 responds also to molecules from other bacterial pathogens. Here we analyzed
a variety of Gram-positive and Gram-negative pathogens and found that apart from staphylococci only certain enterococcal
strains have the capacity to stimulate FPR2/ALX. Most of the analyzed Enterococcus faecium but only sporadic Enterococcus
faecalis strains released FPR2/ALX-stimulating molecules leading to neutrophil calcium ion fluxes, chemotaxis, and
complement receptor upregulation. Among ten test strains vancomycin-resistant E. faecium had a significantly higher
capacity to stimulate FPR2/ALX than vancomycin-susceptible strains, suggesting an association of strong FPR2/ALX
activation with health-care associated strains. The enterococcal FPR2/ALX agonists were found to be peptides or proteins,
which appear, however, to be unrelated to staphylococcal PSMs in sequence and physicochemical properties. Enterococci
are among the most frequent invasive bacterial pathogens but the basis of enterococcal virulence and immune activation
has remained incompletely understood. Our study indicates that previously unrecognized proteinaceous agonists
contribute to Enterococcus-host interaction and underscores the importance of FPR2/ALX in host defense against major
endogenous bacterial pathogens.
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Introduction
Mammalian immune cells have the capacity to detect secreted
or surface-attached bacterial molecules, which are called patho-
gen-associated molecular patterns (PAMPs). Upon activation by
PAMPs, the host responds with inflammation and activation of the
immune system. However, most PAMPs do not represent
virulence factors and are produced by both pathogens and
commensals [1]. Formylated peptides are released by all kinds of
bacteria and are sensed by the formyl-peptide receptor 1 (FPR1),
a G-protein coupled receptor on mammalian leukocytes [2,3].
Formylated peptides elicit neutrophil influx via FPR1 in vivo and
activate neutrophils to release IL-8 and upregulate the comple-
ment receptor CD11b [4].
We have recently demonstrated that the FPR1-related formyl-
peptide receptor 2 (FPR2/ALX), which responds only weakly to
formylated peptides [4], is strongly activated by S. aureus peptide
toxins named phenol-soluble modulins (PSMs) [5]. PSMs have
cytolytic properties at micromolar concentrations and represent
crucial virulence factors in highly virulent S. aureus lineages such as
the community-associated methicillin-resistant S. aureus (CA-
MRSA) USA300 and USA400 [6]. PSMs have also been shown
in vitro and in vivo to contribute substantially to recruiting and
activating neutrophils in CA-MRSA infections [6]. Of note, S.
aureus also secretes the FLIPr protein, a highly specific inhibitor of
human FPR2/ALX [7], which supports the notion that PSM-
FPR2/ALX interactions are crucial in S. aureus infections and can
be modulated by the pathogen. The extent of PSM release and
corresponding FPR2/ALX-mediated neutrophil responses has
recently been shown to be closely related to the virulence potential
of staphylococci. Most pathogenic staphylococcal species bear psm
genes in their genomes and produce PSMs, while both are usually
absent from commensal species [8]. These findings indicate that
FPR2/ALX is crucial in staphylococcal infections and may
instruct the innate immune system about the virulence of an
invading clone. However, it has remained unclear if FPR2/ALX
responds only to staphylococcal pathogens or whether it may have
a broader role in bacterial infections.
Enterococcus faecium and Enterococcus faecalis are colonizers of the
human intestine and frequently cause opportunistic infections [9].
The two species seem to encode only a limited set of virulence
factors; the mechanisms governing enterococcal pathogenicity
have remained incompletely understood [9]. The fast resistance
gain has made E. faecium an almost equally frequent cause of
infection as E. faecalis [10,11]. For the latter, a cytolysin and
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so-called sex pheromone plasmids contribute to the induction of
endocarditis in animal infection models [12,13,14]. Plasmid-
encoded pheromone peptides direct transformation competence
and some of these peptides, although lacking N-terminal formyl
groups, have been shown to activate neutrophils via FPR1
[15,16,17]. Notably, it has remained unclear if enterococci or
other human pathogens besides staphylococci release agonists of
the FPR2/ALX receptor.
In an attempt to explore if FPR2/ALX is specific to
staphylococcal bacterial infections or responds also to other
microbes, we compared the capacities of bacterial pathogens to
activate FPR2/ALX. Among several tested Gram-positive and
Gram-negative species, only enterococcal isolates activated FPR2/
ALX. This property was frequent among E. faecium but only rarely
found in E. faecalis isolates. Interestingly, it was significantly
associated with vancomycin resistance. The E. faecium FPR2/ALX
agonists turned out to be of proteinaceous nature and to be
probably unrelated to PSMs in terms of sequence, chromato-
graphic behavior, synergistic haemolysis.
Materials and Methods
Bacterial strains, growth, and culture filtrates
Bacterial strains (Table 1) were grown at 37uC in tryptic soy
broth (TSB) (AppliChem) for 17 h under agitation. Bacterial
culture filtrates were obtained by centrifugation (10 min, 4uCa t
50006g) of overnight cultures grown in TSB and filtered through
0.2-mm pore size filters. Sterility of the samples was confirmed by
plating aliquots on TSB agar plates. Enterococcal culture filtrates
to be compared in a given experiment were standardized to the
same optical density. Clinical isolates were identified to the species
level using a Vitec 2 system (bioMerieux) and vancomycin
resistance was detected by Vitec 2 or ellipsometry test (AB
Biodisc) as described recently [18]. The identity of some isolates
was also confirmed via matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry analysis (Axima Assurance,
Shimadzu).
Measurement of calcium ion fluxes in HL60 cells and
neutrophils
Recently described HL60 cells stably transfected with human
FPR1 and FPR2/ALX [19,20] were grown in RPMI medium
(Biochrom) supplemented with 10% FCS (Sigma-Aldrich), 20 mM
HEPES (Biochrom), penicillin (100 units ml
21), streptomycin
(100 mgm l
21, GIBCO), and 16Glutamax (GIBCO). Transfected
cells were grown in the presence of G418 (final concentration
1m gm l
21, Biochrom). Human neutrophils were isolated from
blood of healthy volunteers by standard Histopaque/Ficoll
gradient centrifugation [21]. To monitor calcium ion fluxes,
neutrophils were loaded with the calcium-sensitive dye Fluo-3-AM
(Molecular Probes) as described recently [5]. Neutrophils (1610
6
cells ml
21) were challenged with bacterial culture filtrates or
synthetic FPR1 or FPR2/ALX ligand peptides. for 15 s and
diluted in RPMI medium containing 0.05% human serum
albumin (HSA). As positive controls, the synthetic peptides fMLF
(20 nM; Sigma-Aldrich) or MMK1 (50 nM; LESIFRSLLFRVM-
NH2, synthesized by EMC Microcollections), which are known to
be highly specific agonists for FPR1 [22,23,24] or FPR2/ALX
[5,23,24,25], respectively, were used. Thereafter, calcium influx
into the cytoplasm was measured via flow cytometry with
a FACSCalibur (BectonDickinson). In order to block FPR2/
ALX-dependent calcium influx, the S. aureus-derived specific
inhibitor FLIPr was used. This molecule is known to specifically
inhibit FPR2/ALX with only little inhibitory activity towards the
related FPR1 [5,7,26]. Neutrophils were pre-incubated with FLIPr
at a final concentration of 1 mgm l
21, for 20 min at room
temperature under agitation.
Neutrophil chemotaxis
Chemotaxis of neutrophils towards bacterial culture filtrates or
synthetic peptides was determined by using fluorescence-labelled
Table 1. Bacterial strains.
Strains Description
Enterocococcus faecalis:
BK4752, BK4737, BK4714, BK4684 vancomycin-susceptible, isolated from human blood cultures
a
ST4138 vancomycin-susceptible, isolated from human feces
a
VRE366, V583 vancomycin-resistant, isolated from human feces
a; [40]
Enterococcus faecium:
BK4705, BK4689, AN4639, BK2241 vancomycin-susceptible, isolated from human blood cultures
a
BK526, BK474, BK463 vancomycin-resistant, isolated from human blood cultures
a
ST4144 vancomycin-sensitive, isolated from human feces
a
VRE517 vancomycin-resistant, isolated from human feces
a
VRE392 vancomycin-resistant
a
Escherichia coli BK2324 isolated from human blood culture
a
Staphylococcus aureus USA300 LAC CA-MRSA [41]
Staphylococcus aureus USA400 MW2 CA-MRSA [42]
Streptococcus agalactiae SK43 [43]
a
Yersinia enterocolitica WA-314 Serotype O:8 [44]
a
Yersinia pseudotuberculosis O1b Serotype O1b [45]
a
aFrom the strain collection of the diagnostics unit of the Medical Microbiology and Hygiene department, University of Tu ¨bingen.
doi:10.1371/journal.pone.0039910.t001
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trans-well filter as described recently [21]. Culture filtrates or
synthetic peptides were applied as stimuli at the indicated
concentrations. To measure the influence of FLIPr, cells were
pre-incubated with FLIPr at final concentrations of 10 mgm l
21 for
20 min at room temperature under agitation. The relative
fluorescence was measured, subtracted for the buffer control,
and given as percentage of the positive control (25 nM MMK1).
CD11b expression on human neutrophils
To test whether enterococcal culture filtrates promote upregula-
tion of CD11b, 1610
6 neutrophils per well were applied to 100 ml
RPMI with 0.05% HSA in 96 well round-bottom plates and
100 ml of culture filtrates were added to achieve a final concen-
tration of 3% culture filtrate. After incubation for 60 min at 37uC,
stimulation was stopped by centrifugation (8 min, 4uC at 3506g).
Then, neutrophils were washed with ice-cold Dulbecco’s Phos-
phate-Buffered Saline (DPBS; PAA Laboratories) (7 min at 3506
g), anti-CD11b-PE or IgG-PE isotype control (1:40 dilution; BD
Pharmingen) were added, and samples were incubated for 30 min
at 4uC in the dark. Afterwards, cells were washed with 200 ml ice-
cold DPBS again and the pellets were resuspended in 300 ml
DPBS. The samples were analyzed via flow cytometry with
a FACSCalibur. For elucidating the inhibitory influence of FLIPr,
PMN were incubated for 20 min at room temperature with
1 mgm l
21 final concentration of FLIPr. In order to inactivate any
LPS trace contamination polymyxin B (Sigma-Aldrich) was added
at a final concentration of 10 mgm l
21.
Detection of PSM peptides by reversed-phase high-
pressure liquid chromatography/electrospray mass
spectrometry (RP-HPLC/ESI-MS)
The search for PSM peptides in enterococcal supernatants was
performed using RP-HPLC/ESI-MS as described previously [8].
To that end, enterococcal culture filtrates from 8 h and 24 h of
growth in shaken TSB cultures were applied and compared with
culture filtrate of S. aureus USA300 (strain LAC) grown under the
same conditions.
Proteolytic stability of calcium ion flux inducers
To elucidate if FPR2/ALX-activating compounds in E. faecium
supernatants are of proteinaceous nature, culture filtrates or the
FPR2/ALX-specific agonist MMK1 were treated with an un-
specific proteinase as described recently [21]. We used 1 unit ml
21
of proteinase K from Tritirachium album (immobilized on EupergitH
C; Sigma-Aldrich) to incubate the samples for 1 h at 37uC.
Proteinase K EupergitH C beads were subsequently removed by
centrifugation at low speed (10 min at 2506 g). In order to
elucidate whether potential ligands were in fact degraded by
proteinase K control samples were treated with beads, which had
been boiled for 1 h at 99uC prior to incubation with culture
filtrates. Proteolytically digested culture filtrates were used in the
calcium flux assay with FPR2/ALX-transfected HL60 cells
described above.
Statistical methods
All statistical analyzes in this study were performed using Prism
5.04 software (GraphPad). Differences were analyzed for signifi-
cance with the two-tailed Student’s t-test or one-way ANOVA
with Bonferroni’s post test as indicated.
Results
FPR2/ALX does not respond to non-staphylococcal
pathogens except E. faecium
Our previous study demonstrated a correlation of virulence
potential with the capacity to activate FPR2/ALX among
staphylococci, but it has remained unclear if this applies only to
staphylococcal or to further bacterial pathogens [8]. In order to
address this question, we studied the response of FPR2/ALX-
transfected HL60 cells to culture filtrates of several important
Gram-positive (Streptococcus agalactiae, Enterococcus faecalis, Enterococcus
faecium) and Gram-negative (Escherichia coli, Yersinia enterocolitica,
Yersinia pseudotuberculosis) pathogens. The CA-MRSA strains
USA300 and USA400 were included as positive controls. In
initial experiments, we measured calcium ion fluxes as a readout of
leukocyte activation and chemotaxis. Untransfected HL60 cells
showed no response even at the highest concentrations used (data
not shown). FPR1-transfected HL60 responded in a dose-de-
pendent fashion at relatively low rates, which were similar for all
the tested strains except for E. faecium, which induced approxi-
mately two-fold higher calcium ion fluxes (Fig. 1A). These data are
in agreement with the notion that all bacteria release formylated
peptides at about similar levels [27,28].
Figure 1. Induction of calcium ion flux in FPR1-transfected (A)
or FPR2/ALX-transfected (B) HL60 cells. Data represent means 6
SEM of 3 independent experiments with 3 different culture filtrates.
doi:10.1371/journal.pone.0039910.g001
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ALX-transfected HL60, which is in agreement with our previous
findings [5]. Culture filtrates from E. faecalis, E. coli, S. agalactiae, Y.
enterocolitica, and Y. pseudotuberculosis exhibited only weak FPR2/
ALX-stimulating capacities, which did not exceed the FPR1-
stimulating activities. However, E. faecium stimulated a strong
response in FPR2/ALX-transfected HL60, which was much
higher than in FPR1-transfected cells, but not as strong as the
FPR2/ALX-dependent response to CA-MRSA strains (Fig. 1B).
FPR2/ALX stimulation is a frequent trait in E. faecium but
rare in E. faecalis
Ten E. faecium and eight E. faecalis strains, all clinical isolates
from either stool samples or blood cultures, were compared for
their FPR2/ALX-stimulating capacities to elucidate the preva-
lence of this property among clinical strains. Culture filtrates of
eight of the E. faecium strains, of which three were vancomycin-
resistant, exhibited substantial FPR2/ALX-specific activities,
while in two other isolates the activities were weak (Fig. 2A). In
contrast, the tested E. faecalis strains induced hardly any detectable
activity in FPR2/ALX-transfected HL60 with only one exception.
This E. faecalis strain, an isolate from a bacteremia patient, showed
an extraordinarily high level of FPR2/ALX activation. Together,
these findings suggest that FPR2/ALX activation may be rare
among E. faecalis isolates, but very strong in certain strains.
There was no significant association of the FPR2/ALX-
activating capacity of enterococcal strains with origin from
intestinal colonization versus invasive infection. However, among
the ten strains tested here vancomycin-resistant E. faecium
exhibited significantly higher FPR2/ALX-stimulating properties
than vancomycin-susceptible strains (Fig. 2B), suggesting that
strong FPR2/ALX activation may be more frequent in health-care
associated strains.
E. faecium induces chemotaxis and complement receptor
upregulation in human neutrophils in a FPR2/ALX-
dependent manner
Culture filtrates of selected E. faecium and E. faecalis strains
induced calcium fluxes in human neutrophils in a dose-dependent
manner (Fig. 3A). In order to assess the role of FPR2/ALX in
enterococcal neutrophil activation we used the FLIPr protein,
which has been proven to be a highly specific inhibitor of FPR2/
ALX [5,7,29]. FLIPr had no significant impact on the PMN-
stimulating activity of a synthetic FPR1 ligand (fMLF) [7] but
completely blocked the activity of a synthetic FPR2/ALX ligand
peptide (MMK1) [7] (Fig. 3B) thereby confirming the specificity of
FLIPr. The stimulating activities from E. faecalis could only slightly
be inhibited by FLIPr (Fig. 3B), which is in agreement with the low
FPR2/ALX-stimulating capacity in E. faecalis supernatants.
Furthermore, this suggests that most of the neutrophil stimulation
was mediated via FPR1. However, FLIPr had a stronger capacity
to inhibit calcium fluxes stimulated by E. faecium culture filtrates in
neutrophils, indicating that FPR2/ALX plays a more important
role in neutrophil activation by E. faecium compared to E. faecalis.
Similar results were obtained when neutrophil chemotaxis and
CD11b upregulation in response to two selected E. faecium strains
were studied (Fig. 3C, D).
E. faecium FPR2/ALX agonists are proteinaceous without
obvious similarity to staphylococcal PSMs
While the chance to detect potential psm-related genes in
bacterial genomes is limited because several PSM peptides show
only low sequence similarities, at least the amino acid sequences of
the PSMb peptide class exhibit considerable conservation among
different staphylococcal species [8]. Furthermore, the psmb genes
are long enough to be included in genome open reading frame
annotations. However, when we screened the available entero-
coccal genome sequences for genes with similarity to staphylococ-
cal psm genes, we did not find any related sequences. Furthermore,
when we analyzed culture filtrates from E. faecalis strains with
FPR2/ALX-activating capacities that are in the range of those
shown previously for some staphylococcal species with detectable
PSM production [8], no peaks at PSM-characteristic elution times
were detected using RP-HPLC/ESI-MS (Fig. 4A). Moreover, the
capacity of enterococcal strains to activate FPR2/ALX did not
correlate with synergistic hemolytic activity in the culture filtrates
(data not shown), which is a typical property of staphylococcal
PSMs [30,31]. However, when E. faecium filtrates were treated with
proteinase K, their capacities to stimulate FPR2/ALX-transfected
HL60 were completely abolished. The inhibitory effect of
proteinase K was not observed when the enzyme had been heat-
inactivated prior to incubation with E. faecium and E. faecium VRE
culture filtrates (Fig. 4B). Taken together, these data indicate that
Figure 2. Calcium influx stimulated by enterococcal culture filtrates of various clinical blood culture or stool isolates. (A) Activation of
FPR2/ALX-transfected cells by 3% E. faecium or E. faecalis culture filtrates. (B) Significantly stronger FPR2/ALX activation through 3% culture filtrates
from vancomycin-resistant E. faecium (VRE) compared to vancomycin-sensitive E. faecium (VSE). Of each, VRE and VSE, five strains were analyzed. Data
represent means 6 SEM of 3 independent experiments and at least 3 different culture filtrates. P-value for Figure 2B was determined by the two-
tailed Student’s paired t-test. **** p,0.0001.
doi:10.1371/journal.pone.0039910.g002
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appears that these ligands are not PSM-related.
Discussion
While most of the known PAMP receptors sense molecules from
major groups of bacteria or viruses, the FPR2/ALX receptor
appears to respond only to a limited number of Gram-positive
bacterial pathogens. Our study indicates that in addition to most
staphylococcal pathogens and opportunists, FPR2/ALX can also
detect molecules from E. faecium and selected E. faecalis clones.
Staphylococci and enterococci are constituents of the skin and
intestinal mammalian microflora, respectively, and together they
are responsible for a majority of severe invasive human infections
[10,11,32,33]. It may be beneficial for the mammalian innate
immune systems to use a leukocyte receptor that can specifically
detect many of the most frequent bacterial pathogens and direct
the recruitment and activation of neutrophils [34,35].
The staphylococcal FPR2/ALX ligands, the PSM peptides, are
important virulence factors and also have crucial roles in biofilm
formation [5,6,36]. Therefore, FPR2/ALX has been proposed to
sense not only the presence of invading microbes but also instruct
the innate immune system about the virulence potential of the
invaders [8]. It remains unclear if this notion also holds true for the
enterococcal FPR2/ALX ligands. However, the fact that the
source of the enterococcal strains from gut or from invasive
infection and the level of synergistic hemolysis did not correlate
with the capacity to stimulate FPR2/ALX suggests that the
enterococcal FPR2/ALX ligands may not contribute much to
enterococcal virulence. Nevertheless, the significant association of
strong FPR2/ALX-agonistic activity with vancomycin resistance
may indicate that health care-associated E. faecium have a stronger
tendency to stimulate FPR2/ALX than community-associated E.
faecium. We can only speculate about possible reasons for the large
differences in the release of FPR2/ALX-stimulating activities
among the various enterococcal strains. Expression of bacterial
modulins such as PSMs is often controlled by regulatory
mechanisms [26,37] and certain modulin genes can be exchanged
by horizontal gene transfer [38]. Thus, it is possible that expression
of the enterococcal ligand proteins or peptides varies because of
Figure 3. Enterococcal supernatants induce calcium influx and chemotaxis in human neutrophils. (A) Culture supernatants of E. faecalis
and E. faecium, both vancomycin-resistant and vancomycin-sensitive, activate human leukocytes at different levels. (B) Activation of human
leukocytes by E. faecium culture filtrates is stronger inhibited by the FPR2/ALX-specific inhibitor FLIPr than by E. faecalis culture filtrates. (C)
Chemotaxis induced by E. faecium culture supernatants is inhibited by the FPR2/ALX-specific inhibitor FLIPr. (D) CD11b upregulation by E. faecium
and E. faecium VRE 3% culture filtrates can be inhibited by FLIPr. Data represent means 6 SEM of 3 independent experiments with 3 different culture
filtrates. P-values were determined by one-way ANOVA with Bonferroni’s post test. * p,0.05, ** p,0.001, *** p,0.0005, **** p,0.0001; ns, non-
significant.
doi:10.1371/journal.pone.0039910.g003
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genetic elements.
In the present study, we have demonstrated that the E. faecalis
FPR2/ALX agonists are proteinaceous, but their exact nature
remains to be elucidated. FPR2/ALX responds to a variety of host
or microbial peptides with unrelated sequences. The ligand
signatures have remained largely elusive and are possibly defined
by peptide secondary structure [5,6]. Our attempts to identify
potential agonist genes in the available E. faecium genomes failed,
supporting our notion that the enterococcal FPR2/ALX ligands
are no close homologs of PSM peptides. However, this does not
exclude the possibility that E. faecium genomes contain psm-like
genes, owing to the fact that also staphylococcal psm genes are
frequently unrelated between species. The enterococcal ‘sex
pheromone’ peptides cAM373 and cPD1 previously identified as
chemotactic ligands for human leukocytes, are unrelated in
sequences and lengths to PSMs and did not stimulate FPR2/
ALX (data not shown). Thus, identification of the enterococcal
FPR2/ALX agonists will require a comprehensive fractionation
and activity testing approach.
The FPR2/ALX-activating capacities of enterococcal culture
filtrates were considerably lower than those of CA-MRSA and the
amounts required for inducing IL-8 and oxidative burst were
much higher than those required to elicit calcium ion influx and
chemotaxis (Fig. 3 and data not shown), which is in agreement
with our recent finding that the amounts of FPR2/ALX ligands
often differ between aggressive and opportunistic bacterial
pathogens [8]. Since formyl-peptide receptor ligands can be active
already at picomolar concentrations [4,5,24] and our observations
suggest that the enterococcal FPR2/ALX ligands may be pro-
duced only at low levels, we expect identification of the chemical
nature of enterococcal FPR2/ALX agonists to be extremely
difficult.
Although many molecules, such as aggregation substance,
cytolysin, capsule, sex pheromones, pili, glycolipids, or cell wall-
anchored surface proteins, have been implicated in enterococcal
virulence, how the innate immune system senses enterococci has
remained incompletely understood [9,39]. Our study indicates
that there are proteinaceous mediators involved in Enterococcus-host
interaction that await detailed characterization regarding chemical
nature and role in virulence. Notably, our data underscore the
importance of FPR2/ALX in Gram-positive bacterial infections
and indicate that FPR2/ALX should be considered as a target for
anti-infective and anti-inflammatory therapies.
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